Shandong Huashi Import & Export Co., Ltd.
Product
Current Position: Home > Product >Linocaine hydrochloride
Linocaine hydrochloride
  • Brand:HuaShang
  • Model:25kg/drum
  • Purity:99%
  • Cas:6108-05-0
  • Createtime: 2026-04-14
  • Updatetime: 2026-09-30
Product Details
useage Industrial use
deliveryInfo
appearance White crystalline powder
Stability Stable under normal conditions; aqueous solution resistant to acid/alkali, heat-stable after autoclaving
aliasen
supplyCapacity 50000Metric Ton/Month
Solubility Soluble in water (50 mg/mL), ethanol, chloroform; insoluble in diethyl ether
harbor Qingdao,China
minorder 1KG
Melting Point 75–79 °C
  • Purity (HPLC): ≥99.0%
  • Appearance: White crystalline powder
  • Moisture (Karl Fischer): 5.0–6.0% (monohydrate)
  • Residue on Ignition: ≤0.1%
  • Heavy Metals: ≤10 ppm
  • Single Impurity: ≤0.1%
  • Total Impurity: ≤0.5%
  • Assay (Titration): 98.5–101.5% (USP)

  • Applications

    4.1 Local Anesthetic

    • Mechanism: Amide-type local anesthetic blocking voltage-gated sodium channels in neuronal membranes, inhibiting action potential generation/propagation for reversible pain loss.
    • Usage Scenarios:
      • Dentistry: Infiltration/nerve block for tooth extraction, root canal, periodontal surgery.
      • Surgery: Surface/infiltration/epidural anesthesia for minor procedures (e.g., suturing, skin biopsy).
      • Emergency Medicine: Topical anesthesia for wound debridement, burn care, endotracheal intubation.
      • Obstetrics: Pudendal nerve block for vaginal delivery pain relief.

    4.2 Antiarrhythmic Agent 

    • Indication: Treatment/prevention of ventricular arrhythmias (e.g., premature ventricular contractions, ventricular tachycardia/fibrillation) post-myocardial infarction or during cardiac surgery.
    • Mechanism: Reduces sodium influx into myocardial Purkinje fibers, slowing phase 0 depolarization and suppressing ectopic automaticity without affecting normal conduction.

    4.3 Other Medical Uses

    • Neuropathic Pain: Topical/transdermal formulations for postherpetic neuralgia, diabetic neuropathy, and chronic regional pain syndrome.
    • Anti-Inflammatory: Inhibits neutrophil/macrophage activation and pro-inflammatory cytokine (IL-1β, IL-6) release; used in postoperative pain management.
    • Oncology Research: Investigated for anti-tumor effects (inhibits cancer cell proliferation/migration via upregulating miR-145 and suppressing MEK/ERK/NF-κB pathways).

    4.4 Research & Industrial

    • Neuroscience: Tool for studying neuronal excitability and sodium channel function in vitro/in vivo.
    • Pharmaceutical Intermediate: Raw material for lidocaine formulations (injections, creams, patches, gels).

    5. Safety Information

    • Hazard Codes: Xn (Harmful)
    • Risk Statements: R22 (Harmful if swallowed)
    • Safety Statements: S36 (Wear suitable protective clothing)
    • UN Number: UN 2811 (6.1/PG 3, Toxic solid)
    • WGK Germany: 3 (Highly hazardous to water)
    • Toxicity: Oral LD50 (rat): 207 mg/kg; may cause CNS toxicity (dizziness, seizures) or cardiac arrhythmia at high doses.
    • Handling: Use fume hood, nitrile gloves, safety goggles; avoid inhalation, skin/eye contact.